Client Alerts

Skilled in the Art: Amgen and Sanofi Go Back to the Biotech Future at the Federal Circuit + Crowell Helps Vizzy Score Trademark Win Over Brizzy

In the News
Law.com
It's the Battle of Big Pharma, again, at the Federal Circuit

Director Jorge A. Goldstein, Ph.D. was mentioned in the blog post "Skilled in the Art: Amgen and Sanofi Go Back to the Biotech Future at the Federal Circuit + Crowell Helps Vizzy Score Trademark Win Over Brizzy," published by LAW.COMThe blog post discusses the second trial for Amgen v. Sanofi and how the case is raising cutting-edge questions about how to patent antibody-based therapies.